TGFB2 and lung adenocarcinoma: Further evidence for TGFB2 versatility is that 2 TGFB2 ligand mutations Cys246Tyr and Cys407Ser share a lung adenocarcinoma phenotype with a mutation in β8Cys@1 of INHBA Cys244Tyr.